Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies (2019)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; NORONHA, NÁDIA DE CÁSSIA - FCFRP ; MIZUKAMI, AMANDA - FMRP ; COMINAL, JUÇARA GASTALDI - FCFRP ; ROCHA, JOSÉ LUCAS MARTINS - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1186/s13287-019-1224-y
- Subjects: BIOMATERIAIS; CÉLULAS ESTROMAIS; CITOTOXINAS; FÁRMACOS
- Keywords: Mesenchymal stromal cells; Priming; Cell therapy; Pro-inflammatory cytokines; Pharmaceutical drugs; Biomaterials; Culture conditions
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Stem Cell Research & Therapy
- ISSN: 1757-6512
- Volume/Número/Paginação/Ano: v. 10, n. 1, art. 131, [21] p., 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
NORONHA, Nádia de Cássia et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Research & Therapy, v. 10, n. 1, p. [21] , 2019Tradução . . Disponível em: https://doi.org/10.1186/s13287-019-1224-y. Acesso em: 25 abr. 2024. -
APA
Noronha, N. de C., Mizukami, A., Caliári-Oliveira, C., Cominal, J. G., Rocha, J. L. M., Covas, D. T., et al. (2019). Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Research & Therapy, 10( 1), [21] . doi:10.1186/s13287-019-1224-y -
NLM
Noronha N de C, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Farias KCRM de. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies [Internet]. Stem Cell Research & Therapy. 2019 ; 10( 1): [21] .[citado 2024 abr. 25 ] Available from: https://doi.org/10.1186/s13287-019-1224-y -
Vancouver
Noronha N de C, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Farias KCRM de. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies [Internet]. Stem Cell Research & Therapy. 2019 ; 10( 1): [21] .[citado 2024 abr. 25 ] Available from: https://doi.org/10.1186/s13287-019-1224-y - Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC
- Improving wave-induced motion bioreactor performance for human mesenchymal stromal cell expansion
- CAR-T cells for cancer treatment: current design and next frontiers
- Mesenchymal stromal cells in viral infections: implications for COVID-19
- Platforms for clinical-grade CAR-T cell expansion
- Technologies for large-scale umbilical cord-derived MSC expansion: Experimental performance and cost of goods analysis
- Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers
- A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
- Production of recombinant coagulation factors:: are humans the best host cells?
- Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
Informações sobre o DOI: 10.1186/s13287-019-1224-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
